Overview

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx (Bimekizumab)

Status:
RECRUITING
Trial end date:
2027-05-03
Target enrollment:
Participant gender:
Summary
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Phase:
PHASE1
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
bimekizumab